Skip to main content
Pixium Vision logo

Pixium Vision — Investor Relations & Filings

Ticker · ALPIX ISIN · FR001400JX97 LEI · 96950046OPLRLKKEOO08 PA Manufacturing
Open in API
Filings indexed 440 across all filing types
Latest filing 2017-02-14 Regulatory Filings
Country FR France
Listing PA ALPIX

About Pixium Vision

https://www.pixium-vision.com/

Pixium Vision was a bioelectronics company that developed bionic vision systems to restore partial sight for patients with retinal diseases. Its core technology, the PRIMA System, is a photovoltaic subretinal implant designed to treat vision loss from advanced atrophic dry age-related macular degeneration (dry AMD). The system uses specialized glasses to project near-infrared light onto the implant, which converts the light into electrical signals to stimulate retinal cells and create a form of prosthetic vision. The company's assets, including the PRIMA technology and its ongoing European pivotal trial (PRIMAvera), were acquired by Science Corporation in late 2023. The trials and device manufacturing are now sponsored by La Science SAS.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated February 14, 2017, announcing that Pixium Vision's IRIS®II system received 'Statut-1 NUB' (Neue Untersuchungs- und Behandlungsmethoden) status in Germany. This status is crucial for negotiating reimbursement rates within the German statutory health insurance system. The content focuses on a specific regulatory/reimbursement milestone (NUB status) related to a medical device, rather than a full financial report (10-K, IR), a general earnings announcement (ER), or a management discussion (MDA). Since it is an announcement detailing a specific regulatory/reimbursement development that impacts market access, it fits best under 'Regulatory Filings' (RNS) as a general regulatory announcement, or potentially 'Capital/Financing Update' (CAP) if the focus was on securing funding, but RNS is the most appropriate general category for non-standard regulatory milestones not covered by other specific codes like DVA or LTR. Given the options, RNS serves as the best fit for a specific, non-financial, regulatory/market access update that isn't a standard report announcement.
2017-02-14 French
Information relating to the total number of voting rights and shares making up the capital
Share Issue/Capital Change Classification · 95% confidence The document is a press release dated January 23rd, 2017, announcing the 'total number of voting rights and shares composing the share capital as at December 31, 2016.' This type of announcement, detailing the total number of shares and voting rights, is a specific corporate action related to capital structure and shareholder information, often required for regulatory filings or preceding a general meeting. It is not a full Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). It most closely relates to changes or updates regarding the company's share capital structure. Among the provided codes, 'Share Issue/Capital Change' (SHA) is the most appropriate fit for an official notification detailing the exact number of shares and voting rights outstanding at a specific date, as this forms the basis for capital structure calculations and shareholder rights.
2017-01-23 English
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled "Information relative au nombre total de droits de vote et d'actions composant le capital social de la Société au 31 décembre 2016" and provides a precise count of total voting rights and shares as of a specific date (December 31, 2016), announced on January 23, 2017. This type of mandatory disclosure, detailing the capital structure and voting power, is typically associated with regulatory filings concerning share capital changes or general meeting prerequisites. Since it is a specific announcement about the total number of shares and voting rights, it most closely aligns with a notification regarding the capital structure. While not explicitly a 'Share Issue/Capital Change' (SHA) which usually announces a *change*, this is a mandatory periodic disclosure of the current state of the capital structure. However, given the options, this specific type of announcement—a formal statement of the total number of shares and voting rights—is often categorized under general regulatory disclosures or sometimes linked to proxy/AGM materials. Since it is a formal, periodic disclosure of share count, it fits best under the general 'Regulatory Filings' (RNS) as a specific, non-core financial report, or potentially related to 'Declaration of Voting Results & Voting Rights Announcements' (DVA) if it were related to a vote outcome, but here it is just a static count. Given the nature of mandatory capital structure updates, RNS is the most appropriate general regulatory fallback if a more specific code isn't available. It is not an ER, IR, 10-K, or CT. It is a formal regulatory update, making RNS the best fit among the provided codes for a mandatory, non-financial report disclosure.
2017-01-23 French
Communicated under the obligation to provide permanent information / Other communications
Report Publication Announcement Classification · 99% confidence The document is titled "Pixium Vision's 2017 financial calendar" and explicitly lists dates for future events such as the release of full-year results, quarterly sales, and the Annual General Shareholders' Meeting (AGM). It is a short announcement (3940 chars) detailing the schedule of future corporate events and reports, rather than being one of the reports itself (like 10-K or IR). Since it announces the schedule for various corporate disclosures, including the AGM, it fits best as a general announcement regarding corporate reporting schedules. Given the options, this type of forward-looking schedule announcement, which is not a specific financial report, dividend notice, or management change, is best categorized as a general Regulatory Filing (RNS) or potentially related to the AGM announcement if the AGM date is the primary focus. However, since it covers the entire financial calendar, RNS is the most appropriate general regulatory announcement category for scheduling information that doesn't fit a more specific type like DIV or ER. If the document were solely about the AGM, AGM-R might apply, but it covers the whole year's reporting schedule. Given the nature of announcing future report dates, RNS is the safest general classification.
2017-01-23 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Report Publication Announcement Classification · 99% confidence The document is titled "Calendrier financier 2017 de Pixium Vision" (2017 Financial Calendar for Pixium Vision) and lists future dates for key financial announcements (annual results, quarterly revenue, semi-annual results) and the Annual General Meeting (AGM). It is a short press release announcing a schedule, not the actual financial report or the AGM materials themselves. Since it announces the date of the AGM ('16 mai 2017 Assemblée Générale des actionnaires'), but is not the AGM presentation or voting results, and it announces the release of financial results, the most appropriate classification for an announcement detailing the schedule of future corporate events and reports is Report Publication Announcement (RPA), as it is announcing *when* other reports will be published. It is too specific for a general RNS, and it is not the actual financial report (ER or IR).
2017-01-23 French
Share buybacks / Liquidity contracts Information related to liquidity contracts
Capital/Financing Update Classification · 99% confidence The document is a press release dated January 16, 2017, providing an update on the company's liquidity agreement with Gilbert Dupont, detailing the shares and cash held in the liquidity account as of December 31, 2016, and comparing it to June 30, 2016. This content relates to the management of the company's share capital and market liquidity, which is often disclosed via regulatory announcements or press releases concerning share transactions or capital structure. It is not a full annual report (10-K), an earnings release (ER), or a formal dividend notice (DIV). Since it details specific transactions related to the company's own shares (liquidity provision/management), it most closely aligns with 'Transaction in Own Shares' (POS) or potentially a general 'Regulatory Filing' (RNS) if it were a mandatory filing. Given the specific nature of reporting on the liquidity agreement and the shares held therein, it fits best under POS, which covers share repurchase/issuance activities, as liquidity agreements are mechanisms for managing share supply/demand. However, since it is a press release announcing the status of a liquidity agreement, which is a form of capital management, POS is the most specific fit among the options, although RNS is a strong secondary candidate if POS is interpreted too narrowly as only buybacks/sales. Given the context of managing share availability, POS is selected.
2017-01-17 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.